Business

Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company

Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company.

articleEndonovo Therapeutics, Inc.December 3, 20183/company/endonovo-therapeutics-inc/news/endonovo-therapeutics-announces-strategic-relationship-with-us-authentic-trading-company
Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company

About this update from Endonovo Therapeutics, Inc.

[{"type":"text","content":"\nLOS ANGELES, CA, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) (\"Endonovo\" or the \"Company\"), a commercial-stage developer of non-invasive Electroceutical™ therapies, today announced the company has entered into a non-binding Letter of Intent for a strategic partnership with US Authentic Trading Company (USAT) to act as the exclusive partner to assist with facilitating a relationship between the Company and China.\n Endonovo is among 14 other United States based medical device developers chosen by USAT to handle the distribution into China’s hospital network. USAT has access for accelerated ‘green channel’ medical device approvals and registrations, clinical trial consultative authority and implementation logistics in mainland China. The company anticipates definitive agreements to be executed in the first quarter of 2019. Alan Collier, CEO of Endonovo Therapeutics, stated, “With nearly eight million hospital beds in China and the increased costs and health risks associated with opioid use, I am pleased to be working with the US Authentic Trading Company to ensure SofPulse® is available throughout mainland China. The positive results in reducing pain and edema, combined with eliminating opioid use and dependency is something we are very proud of. We believe that hospitals, treatment centers and medical facilities throughout the World will benefit with SofPulse®.” Lucia Fields, Managing Partner for Origenetics™ stated, “We are so excited to be working with Endonovo Therapeutics and their innovative medical approach to pain therapy. Introducing them to our partner USAT was a real win-win. SofPulse® is an amazing solution at the center of one of the fastest growing health issues—opioid addiction.” About US Authentic Trading Company US Authentic Trading Co., or USAT (www.usauthentictrading.com) is a company based in Los Angeles, CA with a mission to facilitate select small to medium sized clients with entry into the coveted Chinese marketplace. USAT’s aim is to provide a level playing field in China for innovative products to compete with global multi-billion dollar corporations in the healthcare space. USAT offers services such as importation licenses, bonded warehouses, product registrations and sales permits, ...

More updates from Endonovo Therapeutics, Inc.